RN-1734
RN-1734 is a chemical compound known for its role as a selective inhibitor of the TRPV4 ion channel. TRPV4, or transient receptor potential vanilloid 4, is a member of the TRP channel family, which are involved in various physiological processes including osmoregulation, thermoregulation, and mechanosensation.
Mechanism of Action[edit | edit source]
RN-1734 functions by selectively inhibiting the activity of the TRPV4 channel. TRPV4 is a non-selective cation channel that is activated by a variety of stimuli, including mechanical stress, temperature changes, and certain chemical ligands. By inhibiting TRPV4, RN-1734 can modulate the physiological responses mediated by this channel, which are implicated in several pathological conditions.
Pharmacological Effects[edit | edit source]
The inhibition of TRPV4 by RN-1734 has been studied in various contexts:
- Pain Management: TRPV4 is involved in the sensation of pain, particularly in response to mechanical and osmotic stimuli. RN-1734 has been shown to reduce pain responses in animal models, suggesting potential therapeutic applications in pain management.
- Edema and Inflammation: TRPV4 plays a role in the regulation of vascular permeability and inflammation. Inhibition by RN-1734 can reduce edema and inflammatory responses, which may be beneficial in conditions such as pulmonary edema and arthritis.
- Bladder Function: TRPV4 is expressed in the bladder and contributes to bladder function. RN-1734 has been investigated for its effects on bladder overactivity and related disorders.
Research and Development[edit | edit source]
RN-1734 is primarily used as a research tool to study the physiological and pathological roles of TRPV4. Its selective inhibition of TRPV4 makes it a valuable compound for dissecting the specific contributions of this channel in various biological processes.
Safety and Toxicology[edit | edit source]
As a research compound, the safety and toxicological profile of RN-1734 in humans is not well-established. Studies in animal models are ongoing to better understand its potential side effects and therapeutic window.
Also see[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
